Both SFK and AKT/mTOR inhibitors alone strongly reduced growth, whereas the combination had only slight if any additive effect on the growth of t(6;9)-AML blasts from both patients (Fig. 6B). Here, AKT1 is linked to acute myeloid leukemia.